Risk of osteoporotic fracture and hip fracture in patients with chronic obstructive pulmonary disease;Riesgo de fractura osteoporótica y de cadera en pacientes con enfermedad pulmonar obstructiva crónica

Revista Clinica Espanola

Volumn 211, Issue 9, 2011, Pages 443-449

  Diez Manglano J ^a   Lopez Garcia F ^b   Barquero Romero, J ^c   Galofre Alvaro N ^d   Montero Rivas, L ^e   Almagro Mena, P ^f   Soriano, J B ^g  

^a HOSPITAL ROYO VILLANOVA   (Spain)

^b HOSPITAL VEGA BAJA   (Spain)

^c HOSPITAL INFANTA CRISTINA   (Spain)

^d HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^e Especialidad en Oftalmología Hospital Comarcal de la Axarquía Vélez Málaga Málaga   (Spain)

^f HOSPITAL MÚTUA DE TERRASSA   (Spain)

^g Fundacion Caubet CIMERA   (Spain)

Author keywords

COPD; Fracture; Osteoporosis

Indexed keywords

BRONCHODILATING AGENT;

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MALE; SPAIN; SPIROMETRY;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HIP FRACTURES; HUMANS; MALE; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS;

EID: 81955160741     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1016/j.rce.2011.04.010     Document Type: Article

References (34)

1. M. Miravitlles, J.B. Soriano, F. García-Río, L. Muñoz, E. Duran-Tauleria, and G. Sanchez Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities Thorax 64 2009 863 868
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2009) [consultado el 23/05/2010]. Disponible en: http://www.goldcopd.com.
3. A.C. Stone, and L.N. Nici Other manifestations of chronic obstructive pulmonary disease Clin Chest Med 28 2007 553 557 (Pubitemid 47284590)
4. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis and Therapy. Osteoporosis prevention, diagnosis and therapy. JAMA. 2001;285:785-95.
5. J.B. Soriano, J. Zielinski, and D. Price Screening for and early detection of chronic obstructive pulmonary disease Lancet 374 2009 721 732
6. P.L. Westersson, R.K. Lee, M.A. Ketkar, and E.P. Lin Underdiagnosis and undertreatment of osteoporosis Lancet 360 2002 1891
7. G.G. Teng, J.R. Curtis, and K.G. Saag Quality health care gaps in osteoporsis: how can patients, providers, and the health system do a better job? Curr Osteoporos Rep 7 2009 27 34
8. A. Papaioannou, W. Parkinson, N. Ferko, L. Probyn, G. Ioannidis, and E. Jurriaans Prevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in Canada Osteoporos Int 14 2003 913 917 (Pubitemid 38009531)
9. C.E. McEvoy, K.E. Ensrud, E. Bender, H.K. Genant, W. Yu, and J.M. Griffith Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease Am J Respir Crit Care Med 157 1998 704 709
10. S. Singh, and Y.K. Loke An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease Int J Chron Obstruct Pulmon Dis 5 2010 189 195
11. P. Almagro, F. López García, F.J. Cabrera, L. Montero, D. Morchón, J. Díez Grupo EPOC de la Sociedad Española de Medicina Interna Estudio de las comorbilidades en pacientes hospitalizados por descompensación de la enfermedad pulmonar obstructiva crónica atendidos en los servicios de Medicina Interna. Estudio ECCO Rev Clin Esp 210 2010 101 108
12. P. Almagro, F. López García, F.J. Cabrera, L. Montero, D. Morchón, J. Díez Grupo EPOC de la Sociedad Española de Medicina Interna Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study Respir Med 104 2010 253 259
13. B. Roca, P. Almagro, F. López, J. Cabrera, L. Montero, J. Morchón for the ECCO Working Group on COPD, Spanish Society of Internal Medicine Factors associated with mortality in patients with exacerbation of chronic obstructive pulmonary disease hospitalized in General Medicine departments Intern Emerg Med 6 2011 47 54
14. N.R. Anthonisen, J. Manfreda, C.P.W. Warren, E.S. Hersfeld, G.K.M. Harding, and N.A. Nelson Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease Ann Intern Med 106 1987 196 204 (Pubitemid 17009877)
15. WHO Fracture Risk Assessment Tool [consultado el 14/09/2010]. Disponible en: http://www.sheffield.ac.uk/FRAX/.
16. M. Sanjaume, P. Almagro, M. Rodríguez-Carballeira, B. Barreiro, J.L. Heredia, and J. Garau Mortalidad posthospitalaria en pacientes reingresadores por EPOC. Utilidad del índice BODE Rev Clin Esp 209 2009 364 370
17. M. Díaz Curiel, J.J. García, J.L. Carrasco, J. Honorato, R. Pérez Cano, and A. Rapado Prevalencia de osteoporosis determinada por densitometría en la población femenina española Med Clin (Barc) 116 2001 86 88 (Pubitemid 33627551)
18. M. Díaz Curiel, and J. Espinoza Pineda Osteoporosis en el varón en España Rev Esp Enf Metab Oseas 12 2003 1 3
19. G.T. Ferguson, P.M. Calverley, J.A. Anderson, C.R. Jenkins, P.W. Jones, and L.R. Willits Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study Chest 136 2009 1456 1465
20. L. Graat-Verboom, E.F.M. Wouters, F.W.J.M. Smeenk, B.E.E.M. van der Borne, R. Lunde, and M.A. Spruit Current status of research on osteoporosis in COPD: a systematic review Eur Respir J 34 2009 209 218
21. S.L. Silverman, and A.D. Calderon The utility and limitations of FRAX: A US perspective Curr Osteoporos Rep 8 2010 192 197
22. ®-assessment and intervention thresholds for the UK Osteoporos Int 19 2008 1395 1408
23. M.T. Aldámiz-Echevarria Lois, S. Gordo Remartínez, F. de la Calle Prieto, J.M. Hens Gutiérrez, J.L. Fraile González, and A.M. Torres Do Rego Osteoporosis in patients hospitalized in an internal medicine unit Eur J Intern Med 20S 2009 S171
24. E. Casado, M. Larrosa, E. Naval, M. Gallego, A. Gómez, and C. Domingo Osteoporosis en el varón con enfermedad pulmonar obstructiva crónica. Utilidad de la densitometría de falange (AccuDEXA) como método de cribado diagnóstico Reumatol Clin 1 2005 1 7
25. D. Roig-Vilaseca, C. Gómez Vaquero, C. Hoces Otero, and J.M. Nolla Riesgo de fractura calculado con el índice FRAX en pacientes con osteoporosis tratados y no tratados Med Clin (Barc) 134 2010 189 193
26. National Osteoporosis Foundation. Clinical's guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010 [consultado el 14/09/2010]. Disponible en: www.nof.org/professionals/pdfs/ NOF-ClinicianGuide 2009-v7.pdf.
27. A. Vrieze, M.H. de Greef, P.J. Wijkstra, and J.B. Wempe Low bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free mass Osteoporos Int 18 2007 1197 1202 (Pubitemid 47300271)
28. R. Alvarez-Sala La enfermedad pulmonar obstructiva crónica: más allá de los pulmones Rev Clin Esp 210 2010 124 126
29. P.D. Scanlon, J.H. Connett, R.A. Wise, D.P. Tashkin, T. Madhok, and M. Skeans Loss of bone density with inhaled triamcinolone in Lung Heart Study II Am J Respir Crit Care Med 170 2004 1302 1309 (Pubitemid 39657194)
30. R.A. Incalzi, P. Caradonna, P. Ranieri, S. Basso, L. Fuso, and F. Pagano Correlates of osteoporosis in chronic obstructive pulmonary disease Respir Med 94 2000 1079 1084
31. T.C. Mineo, G. Ambrogi, D. Mineo, A. Fabbri, E. Fabbrini, and R. Massoud Bone mineral density improvement after lung volume reduction surgery for severe emphysema Chest 127 2005 1960 1966
32. R. Gómez-Huelgas, V. Buonaiuto, P. Medina, and C.M. San Román EPOC y diabetes, algo más que una simple coincidencia? Rev Clin Esp 210 2010 533 534
33. R. Alvarez-Sala Walter Enfermedad pulmonar obstructiva crónica y diabetes mellitus tipo 2 Rev Clin Esp 210 2010 535
34. C.M. San Román Terán, R. Guijarro Merino, R. Gómez Huelgas, and L. Montero Ribas Epidemiología hospitalaria de la EPOC en España Rev Clin Esp 207 Suppl 1 2007 3 7